Table 2 Investigator descriptions for the 48 networks included in the Sentiworld study
From: The Sentiworld project: global mapping of sentinel surveillance networks in general practice
n | % | |
|---|---|---|
Number of investigators by type (m.d.a = 0) | ||
General practitioners | 48 | 100 |
Paediatricians | 13 | 27.1 |
Nurses | 10 | 20.8 |
Hospital Physicians | 7 | 14.6 |
Microbiologists | 5 | 10.4 |
Internists | 3 | 6.2 |
Number of GPs registered per network (m.d. = 4) | ||
Minimum | 3 | |
Maximum | 2600 | |
Mean | 403 | |
Median | 140 | |
Number of GPs participating in the current year (m.d. = 4) | ||
Minimum | 3 | |
Maximum | 2600 | |
Mean | 368 | |
Median | 130 | |
Percentage of country’s GPs registered in the network (m.d. = 7) | ||
Minimum | 0.1 | |
Maximum | 100 | |
Mean | 12.7 | |
Median | 2.5 | |
Study of GPs representation in the network (m.d. = 8) | ||
Yes | 25 | 62.5 |
Investigator activities (m.d. = 0) | ||
Continuous epidemiologic surveillance | 48 | 100 |
Ad-hoc epidemiologic studies | 10 | 20.8 |
Clinical Trials | 2 | 4.2 |
Financial compensation for GPs (m.d. = 0) | ||
Yes | 14 | 29.2 |
No | 34 | 70.8 |
Compensation according to the activity (m.d. = 0) | ||
Epidemiologic surveillance (n = 48) | 13 | 27.1 |
Ad-hoc epidemiologic studies (n = 10) | 1 | 10.0 |
Clinical Trials (n = 2) | 1 | 50.0 |